During the past decade, The Lindner Clinical Trial Center conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 61 clinical trials were completed, i.e. on average, 70.1% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 32 clinical trials were completed. i.e. 110.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Lindner Clinical Trial Center" #1 sponsor was "Boston Scientific Corporation" with 18 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 17 trials sponsored, "Actelion" with 9 trials sponsored, "Gilead Sciences" with 8 trials sponsored and "United Therapeutics" with 8 trials sponsored. Other sponsors include 112 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Lindner Clinical Trial Center" #1 collaborator was "Medpace, Inc." with 6 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)" with 2 trials as a collaborator and "California Institute for Regenerative Medicine (CIRM)" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "The Lindner Clinical Trial Center" are "Heart Failure" (15 trials), "Coronary Artery Disease" (13 trials), "Pulmonary Hypertension" (13 trials), "Pulmonary Arterial Hypertension" (12 trials) and "Hypertension" (10 trials). Many other conditions were trialed in "The Lindner Clinical Trial Center" in a lesser frequency.

Most popular intervention types in "The Lindner Clinical Trial Center" are "Drug" (91 trials), "Device" (70 trials), "Other" (17 trials), "Biological" (12 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "placebo" (7 trials), "Ambrisentan" (4 trials), "lerodalcibep" (4 trials) and "Macitentan" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Lindner Clinical Trial Center" are 170 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "The Lindner Clinical Trial Center". undefined are not yet recruiting, 13 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 94 completed trials in The Lindner Clinical Trial Center, undefined suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in The Lindner Clinical Trial Center, 8 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 45 trials that are defined as “Not Applicable".